Skip to content

Current ratio at other companies

IAR
Integra LifeSciencesIART
3.4×+2.2×
MiMedx Group logo
MiMedx GroupMDXG
5.4×+0.7×
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
3.5×-0.6×
Solventum logo
SolventumSOLV
1.1×-0.1×
The Beauty Health Company logo
The Beauty Health CompanySKIN
1.8×-5.7×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
5.8×+2.3×

Other financials

Income statement

See full
Revenue$9.6M+3.1%
Gross profit$7.4M+0.8%
Operating income-$1.1M-287%
Net income-$1.4M+76.5%
EPS (diluted)-$0.17+76.4%

Balance sheet

See full
Cash & equivalents$10.8M+26.8%
Total debt$21.7M+5,319%
Total equity$1.8M+109%
Total assets$37.1M+20.2%

Cash flow

See full
Operating cash flow$397.0K+126%
CapEx$23.0K-85.8%
Free cash flow$374.0K+122%

Valuation

See full
Market cap$85.99M+10.0%
Enterprise value$96.88M
P/E5.2×
P/S1.9×

Profitability

See full
Gross margin76.7%+0.1pp
Operating margin7.3%-8.6pp
Net margin37.2%+21.6pp
FCF margin9%

Returns & leverage

See full
Return on equity-173.8%
Debt / equity11.8×

Where this comes from

Calculated from SANUWAVE Health, Inc.’s reported figures.

Based on the most recent quarter.

The official record: SANUWAVE Health, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SANUWAVE Health, Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s current ratio?
SANUWAVE Health, Inc. (SNWV) reported current ratio of 1.3× in Q1 2026.
How has SANUWAVE Health, Inc.'s current ratio changed year-over-year?
SANUWAVE Health, Inc.'s current ratio increased by 253.0% year-over-year, from 0.4× to 1.3×.
What is the long-term trend for SANUWAVE Health, Inc.'s current ratio?
Over 4 years (2021 to 2025), SANUWAVE Health, Inc.'s current ratio has grown at a 105.0% compound annual growth rate (CAGR), from 0.1× to 1.4×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.